Olin Corporation; Huntsman Corporation: OLIN and HUNTSMAN Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Merger
Olin (OLN) and Huntsman (HUN) announced the expiration of the HSR Act waiting period for their proposed merger, satisfying a key closing condition. Shareholders approved the transaction, but regulatory approvals are still required. Olin is a chemical and ammunition manufacturer, while Huntsman is a diversified chemical producer with 2025 revenues of $6 billion.
How this was made
The 30-second read
Why it matters
The announcement removes a key regulatory barrier, reducing deal uncertainty and likely supporting both stocks.
Market read
The news is a material M&A development for two large-cap chemical firms, with potential sector-wide effects.
What to watch
Potential integration challenges and overlapping product lines could dampen expected synergies.
Background
Olin and Huntsman are merging equals; the HSR waiting period expiration is a required antitrust clearance step.
Ticker impact
OLN announced the expiration of the HSR waiting period, clearing a key regulatory hurdle for its merger with Huntsman.
moderate upside as the deal progresses
The news is a primary disclosure of a material M&A step for a large-cap chemical company.
HUN confirmed the HSR waiting period has expired, satisfying a key closing condition for its merger with Olin.
moderate upside as merger proceeds
Same primary disclosure applies to Huntsman, indicating material progress toward deal completion.
Market effects
The chemicals sector may see consolidation pressure as the Olin-Huntsman merger moves forward.
U.S. chemical manufacturers could experience valuation adjustments.
The deal may influence global chemical supply chains and competitive dynamics.
Counterpoint
If regulatory approvals stall after this step, the stock could face a sharp correction.
Key entities
- CompanyOlin Corporation
U.S. chemical and ammunition manufacturer.
- CompanyHuntsman Corporation
Global diversified chemicals producer.
